SGCIA
BRLI

Smith Graham & Co Investment Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-219,167
Closed -$9.04M – 140
2015
Q2 		$9.04M Sell
219,167
-2,420
-1% -$86.8K 1.22% 15
2015
Q1 		$7.81M Sell
221,587
-260
-0.1% -$8.8K 1.06% 29
2014
Q4 		$7.13M Sell
221,847
-13,590
-6% -$393K 1.02% 32
2014
Q3 		$6.61M Sell
235,437
-6,630
-3% -$202K 0.98% 34
2014
Q2 		$7.32M Sell
242,067
-53,760
-18% -$1.48M 1.02% 30
2014
Q1 		$8.19M Buy
295,827
+32,910
+13% +$861K 1.18% 23
2013
Q4 		$6.71M Buy
262,917
+38,250
+17% +$1.18M 0.95% 50
2013
Q3 		$6.71M Buy
224,667
+41,920
+23% +$1.17M 0.97% 36
2013
Q2 		$5.25M Buy
+182,747
New +$5.04M 0.81% 51

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Smith Graham & Co Investment Advisors's BRLI Position: Q3 2015 in Review

Smith Graham & Co Investment Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 219,167 shares — an estimated $9.04M sold.

Smith Graham & Co Investment Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $9.04M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Smith Graham & Co Investment Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Smith Graham & Co Investment Advisors sold 219,167 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $9.04M.
  • Smith Graham & Co Investment Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Smith Graham & Co Investment Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $9.04M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q3 2015, filed 22 Oct 2015.